Status:
COMPLETED
National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin
Lead Sponsor:
Genentech, Inc.
Conditions:
Growth Disorders
Eligibility:
All Genders
Brief Summary
The purpose of this multicenter, open-label, observational, post-marketing surveillance study is to collect long term safety and efficacy information on growth hormone (GH) products: Protropin (somatr...
Eligibility Criteria
Inclusion
- Participants with open epiphyses
- Children of either sex who are treated with Nutropin Depot, Nutropin AQ, Nutropin, or Protropin for the treatment of growth failure
- Participants who are willing to keep follow up appointments throughout the study participation
Exclusion
- Participants treated with a non-Genentech GH preparation
- Participants with closed epiphyses
- Participants with active neoplasia
Key Trial Info
Start Date :
October 1 1985
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
65205 Patients enrolled
Trial Details
Trial ID
NCT00097539
Start Date
October 1 1985
End Date
June 1 2010
Last Update
February 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.